Feedback / Questions
BT2111 (trastuzumab biosimilar) - BiOasis
BT2111: Protection of use/indications patent until 2035
(Bioasis)
-
Jun 21, 2018 -
Corporate Presentation
Patent
https://bioasisprodcdn.azureedge.net/wp-content/uploads/BTI-Corporate-Presentation-June-12-2018.pdf
Jun 21, 2018
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious